To check efficacy of Lodhra Bidalak in allergic redness of eyes.

A Randomized Controlled Clinical Study of Lodhra Bidalak in Simple Allergic Conjunctivitis w.s.r to Kaphaj Abhishyanda. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099104

Enrollment

Registered

2025-12-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Participants suffering from simple allergic conjuctivitis. 1 Age 18 to 60 years 2 Gender both male and female

Exclusion criteria

Exclusion criteria: 1 Participants suffering from other ocular pathology. 2 Post-operative participants. 3 Participants suffering from all other type of conjunctivitis. 4 One eyed patients

Design outcomes

Primary

Measure	Time frame
Reduction of itching. Reduction of burning sensation. Reduction of redness. Reduction of photophobia. Reduction of lacrimation. Reduction of redness. Timepoint: 14 days	—

Secondary

Measure	Time frame
1 Relief from signs and symptoms. 2 To generate supportive clinical evidence for the use of Ayurvedic intervention(Lodhra Bidalak) in Simple Allergic Conjunctivitis. Timepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Santosh Mulik

Bharati Vidyapeeth(Deemed To Be University), College of Ayurveda,Pune- 411043

mulik.santosh@bharatividyapeeth.edu9823491389

Outcome results